Skip to content

Aura Biosciences, Inc. AURA Cash Flow Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
-$112.39M-18.7%-$106.19M-22.2%-$106.47M-27.9%-$101.38M-25.6%-$94.7M-20.4%
$1.15M-3.0%$1.16M-2.8%$1.18M-3.9%$1.18M-11.1%$1.18M-11.1%
$14.63M+18.7%$14.32M+22.1%$13.97M+22.7%$13.03M+18.9%$12.33M+26.2%
-$91.28M-16.0%-$84.74M-6.2%-$88.23M-20.5%-$83.35M-13.6%-$78.71M-9.5%
$362K-73.2%$447K-64.3%$570K-55.2%$866K-15.1%$1.35M+96.5%
$89.37M$89.24M
$77.36M+5,280%$77.16M+4,737%$74.93M-20.3%$71.28M-24.9%$1.44M-98.5%
-$91.64M-14.5%-$85.19M-5.1%-$88.8M-19.2%-$84.22M-13.2%-$80.06M-10.3%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Aura Biosciences, Inc. generate?
Aura Biosciences, Inc. (AURA) generated -$91.3M in operating cash flow over the trailing twelve months.
What is Aura Biosciences, Inc.'s free cash flow?
After $362.0K of capital expenditures, Aura Biosciences, Inc.'s free cash flow was -$91.6M over the trailing twelve months, down 14.5% year over year.
Where does Aura Biosciences, Inc.'s cash flow data come from?
Every line is extracted from Aura Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.